Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Valent Technologies, Llc

Clinical trials sponsored by Valent Technologies, Llc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New flavored chemo drink aims to ease treatment for kids with hard-to-treat cancers Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New flavored chemo drink aims to ease treatment for kids with hard-to-treat cancers

Disease control Ongoing

This early-phase study tests a flavored, drinkable version of the chemotherapy drug irinotecan (VAL-413) combined with another drug (temozolomide) in children and young adults up to age 30 whose solid tumors have come back. The main goal is to find the safest dose and see how the…

Phase 1 • Sponsor: Valent Technologies, LLC • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC